Experimental GLP-1 Med Might Be Breakthrough Against Fatty Liver Disease

MONDAY, June 10, 2024 -- An experimental 'supercharged' form of popular GLP-1 weight-loss meds could help ease fatty liver disease, a new trial suggests.

The drug under development, survodutide, helped up to 83% of patients gain real improvements...